Clinical trial
Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer
NCT00195091 · Memorial Sloan Kettering Cancer Center, Other · Terminated
Key facts
| NCT number | NCT00195091 |
|---|---|
| Title | Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer |
| Official title | A Phase II Study of Tetrathiomolybdate (TM) in Patients With Breast Cancer at Moderate to High Risk of Recurrence |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | Weill Medical College of Cornell University |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Breast Cancer |
| Intervention type | Drug |
| Interventions | Tetrathiomolybdate |
| Enrollment | 16 |
| Start date | Dec 1, 2003 |
| Primary completion | Mar 2, 2023 |
| Completion | Mar 2, 2023 |
| First posted | Sep 19, 2005 |
| Last update posted | May 16, 2025 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: